Core Viewpoint - Guangzheng Eye Hospital announced that neither the company nor its subsidiaries have provided guarantees to any units or individuals outside the scope of the consolidated financial statements, and there are no overdue debts related to guarantees, litigation guarantees, or guarantees arising from judgments against the company [1] Summary by Categories - **Company Guarantees** - The company has not provided any guarantees to entities or individuals outside the consolidated financial statements [1] - **Debt and Litigation Status** - There are no overdue debts associated with guarantees, nor are there any guarantees related to litigation or judgments against the company [1]

Core Viewpoint - The company plans to apply for a comprehensive credit line of up to 650 million yuan from financial institutions by 2025, with a total guarantee amount of 497 million yuan, which represents 441.07% of the latest audited net assets attributable to the parent company [1] Group 1 - The company and its subsidiaries will provide a cumulative guarantee limit of no more than 650 million yuan, valid for 12 months [1] - The wholly-owned subsidiary, Guangzheng New Vision, has initiated a financing lease business of 10 million yuan, with the company providing joint liability guarantees [1] - New Vision Eye Hospital has applied for a credit limit of 20 million yuan, with the company and Guangzheng New Vision providing joint liability guarantees [1]

光正眼科医院集团股份有限公司 截至本公告披露日，光正眼科医院集团股份有限公司（以下简称"公司"） 及控股子公司对外担保总额超过最近一期经审计（归母）净资产 100%，均为公 司、控股子公司、全资子公司及其下属公司间互相担保。敬请投资者关注担保风 险。 证券代码：002524 证券简称：光正眼科 公告编号：2025-072 光正眼科医院集团股份有限公司 关于下属子公司综合授信及担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 近日，公司全资子公司上海光正新视界眼科医院投资有限公司（以下简称 "光正新视界"）下属子公司上海新视界中兴眼科医院有限公司（以下简称"中 兴眼科"）与江苏金融租赁股份有限公司签署了《融资租赁合同》，中兴眼科通 过江苏金融租赁股份有限公司以售后回租方式开展融资租赁业务，融资总额为人 民币 1,000 万元，融资期限为 24 个月。公司为中兴眼科的上述融资回租业务提 供了连带责任担保。 公司全资子公司上海光正新视界眼科医院投资有限公司（以下简称"光正新 视界"）下属子公司上海新视界眼科医院有限公司（以下简称"新视界 ...

Core Viewpoint - Guangzheng Ophthalmology's stock price has shown a year-to-date increase of 24.73%, indicating positive market sentiment despite a recent decline in revenue [2] Financial Performance - As of September 30, 2025, Guangzheng Ophthalmology reported a revenue of 663 million yuan, a year-on-year decrease of 5.05%, while net profit attributable to shareholders was 173,400 yuan, reflecting a significant year-on-year growth of 100.83% [2] - The company has cumulatively distributed 14.75 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3] Stock Market Activity - On October 31, Guangzheng Ophthalmology's stock rose by 2.02%, reaching 4.54 yuan per share, with a trading volume of 35.62 million yuan and a turnover rate of 1.55% [1] - The net inflow of main funds was 595,600 yuan, with large orders accounting for 14.03% of purchases and 12.36% of sales [1] Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 11.99% to 38,700, while the average circulating shares per person increased by 14.07% to 13,186 shares [2] - Notable changes in institutional holdings include an increase in shares held by Noan Multi-Strategy Mixed A and the entry of Jinyuan Shun'an Yuanqi Flexible Allocation Mixed as a new major shareholder [3]

Core Viewpoint - Guangzheng Eye Hospital, established in December 2001 and listed in December 2010, operates in the domestic ophthalmology medical service sector with a chain operation model, possessing brand and scale advantages [1] Group 1: Business Performance - In Q3 2025, Guangzheng Eye Hospital reported revenue of 663 million yuan, ranking 12th in the industry, significantly lower than the top player Aier Eye Hospital's 17.484 billion yuan and the industry average of 2.966 billion yuan [2] - The main business composition includes cataract projects generating 148 million yuan (33.82%) and refractive projects generating 143 million yuan (32.71%) [2] - The net profit for the same period was 380,000 yuan, ranking 11th in the industry, far behind Aier Eye Hospital's 3.367 billion yuan and the industry average of 290 million yuan [2] Group 2: Financial Ratios - As of Q3 2025, Guangzheng Eye Hospital's debt-to-asset ratio was 89.56%, up from 80.68% year-on-year, significantly higher than the industry average of 46.74%, indicating substantial debt pressure [3] - The gross profit margin for Q3 2025 was 36.41%, slightly down from 36.90% year-on-year but still above the industry average of 31.10%, reflecting a competitive profitability position [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 11.99% to 38,700, while the average number of circulating A-shares held per shareholder increased by 14.07% to 13,200 [5] - Among the top ten circulating shareholders, Noan Multi-Strategy Mixed A ranked third with 3.6956 million shares, an increase of 1.3827 million shares from the previous period [5]

Core Viewpoint - On October 27, a total of 10 listed companies had their restricted shares unlocked, with a total market value of approximately 18.54 billion yuan [1] Summary by Category Restricted Share Unlocking - Xiamen Bank (601187) extended the lock-up period for 1.348 billion shares [1] - Guangzheng Eye Hospital (002524) released 2.2245 million shares under equity incentive restrictions [1] - Shapuaisi (603168) released 30,000 shares under equity incentive restrictions [1] - Yifeng Pharmacy (603939) released 195,000 shares under equity incentive restrictions [1] - Jihong Co., Ltd. (002803) released 1.98 million shares under equity incentive restrictions [1] - Mingyang Circuit (300739) released 1.2387 million shares under equity incentive restrictions [1] - Arrow Home (001322) released 800 million shares under pre-issue restrictions [1] - Ruichen Environmental Protection (301273) released 3.70125 million shares under pre-issue restrictions [1] - Jinchengzi (688291) released 6.9 million shares [1] - Weice Technology (688372) released 2.70328 million shares [1]

Core Insights - The company reported a revenue of 663,491,611.66 yuan for the first three quarters of 2025, representing a year-on-year decline of 5.05% [2] - The net profit attributable to shareholders of the listed company was 173,418.14 yuan, showing a significant year-on-year increase of 100.83% [2] Financial Performance - Revenue for the first three quarters of 2025: 663.49 million yuan, down 5.05% year-on-year [2] - Net profit for the same period: 173.42 thousand yuan, up 100.83% year-on-year [2]

Group 1 - High-speed Electric achieved a revenue of 810 million yuan, a year-on-year increase of 30.33%, and a net profit of 36.33 million yuan, up 54.32% year-on-year for the first three quarters [1] - Huaguang Bio reported a revenue of 868 million yuan, a year-on-year increase of 17.98%, and a net profit of 16.33 million yuan, up 146.55% year-on-year for the first three quarters [2] - North Navigation turned a profit with a net profit of 125 million yuan for the first three quarters, compared to a loss in the previous year, with a revenue of 2.468 billion yuan, up 210.01% year-on-year [3] Group 2 - Wukuang New Energy reported a revenue of 5.054 billion yuan, a year-on-year increase of 33.96%, but a net loss of 20.1 million yuan for the first three quarters [4] - Century Rui Er achieved a revenue of 5.110 billion yuan, a year-on-year increase of 5.21%, and a net profit of 41.64 million yuan, up 27.23% year-on-year for the first three quarters [5] - Jiejie Micro reported a revenue of 2.502 billion yuan, a year-on-year increase of 24.70%, and a net profit of 34.7 million yuan, up 4.30% year-on-year for the first three quarters [6] Group 3 - Zhejiang Huaye achieved a revenue of 739 million yuan, a year-on-year increase of 11.08%, and a net profit of 181 million yuan, up 143.68% year-on-year for the first three quarters [7] - Lege Co. reported a revenue of 4.846 billion yuan, a year-on-year increase of 21.92%, but a net profit of 16.9 million yuan, down 36.33% year-on-year for the first three quarters [8] - Huichuan Technology achieved a revenue of 31.663 billion yuan, a year-on-year increase of 24.67%, and a net profit of 4.254 billion yuan, up 26.84% year-on-year for the first three quarters [9] Group 4 - Jieya Co. reported a revenue of 565 million yuan, a year-on-year increase of 38.44%, and a net profit of 67.9 million yuan, up 95.78% year-on-year for the first three quarters [10] - Hengtian Hailong reported a revenue of 829 million yuan, a year-on-year increase of 0.89%, but a net profit of 274,780 yuan, down 93% year-on-year for the first three quarters [11] - Baolidi achieved a revenue of 1.058 billion yuan, a year-on-year increase of 4.57%, and a net profit of 106 million yuan, up 31.25% year-on-year for the first three quarters [12] Group 5 - Feitian Chengxin reported a revenue of 520 million yuan, a year-on-year increase of 3.10%, and a net profit of 10.38 million yuan, up 146.05% year-on-year for the first three quarters [13] - Xiangqiang Co. reported a revenue of 1.237 billion yuan, a year-on-year increase of 9.19%, but a net profit of 171 million yuan, down 5.90% year-on-year for the first three quarters [14] - Guangzheng Eye Care reported a revenue of 663 million yuan, a year-on-year decrease of 5.05%, but a net profit of 17,340 yuan, turning from loss to profit for the first three quarters [15] Group 6 - Sand Technology achieved a revenue of 430 million yuan, a year-on-year increase of 26.94%, and a net profit of 115 million yuan, up 47.52% year-on-year for the first three quarters [16] - Tianhao Energy reported a revenue of 1.941 billion yuan, a year-on-year decrease of 36.05%, and a net profit of 95.74 million yuan, down 27.25% year-on-year for the first three quarters [17] - Yiyuan Communication achieved a revenue of 17.877 billion yuan, a year-on-year increase of 34.96%, and a net profit of 733 million yuan, up 105.65% year-on-year for the first three quarters [18] Group 7 - Zhenhai Co. reported a revenue of 295 million yuan, a year-on-year decrease of 9.96%, and a net profit of 51.69 million yuan, down 8% year-on-year for the first three quarters [19] - Xinda Securities received approval to issue up to 10 billion yuan in corporate bonds for technology innovation [20] - Jingong Steel Structure signed a contract worth 1.23 billion yuan for an overseas project [21] Group 8 - Chuanfa Longmang plans to invest 366 million yuan in a lithium dihydrogen phosphate project [22] - Ningbo Energy plans to invest 58.5 million yuan to establish a joint venture [23] - China Unicom plans to spin off its subsidiary for listing on the Growth Enterprise Market [24] Group 9 - China Unicom reported a revenue of 292.985 billion yuan, a year-on-year increase of 1%, and a net profit of 8.772 billion yuan, up 5.2% year-on-year for the first three quarters [25] - Haigang Co. announced a plan to reduce its shareholding by 0.9965% [26] - Jintongling's subsidiary is facing bankruptcy liquidation [27] Group 10 - Lanshi Heavy Industry plans to transfer 51.02% of its environmental company shares for 14.39 million yuan [28] - Lanshi Heavy Industry's shareholder plans to reduce its stake by 1% [29] - Dongtian Micro reported a revenue of 637 million yuan, a year-on-year increase of 53.91%, and a net profit of 80.03 million yuan, up 99.20% year-on-year for the first three quarters [30] Group 11 - Siling Co. reported a revenue of 581 million yuan, a year-on-year increase of 4.38%, and a net profit of 14 million yuan, up 2.17% year-on-year for the first three quarters [31] - Hanrui Cobalt achieved a revenue of 4.871 billion yuan, a year-on-year increase of 16.49%, and a net profit of 238 million yuan, up 42.57% year-on-year for the first three quarters [32] - Ganfeng Lithium's vice president plans to reduce his stake by 40,000 shares [33] Group 12 - Kaile Co. plans to acquire at least 50% of Kesheng Machinery [34] - Huace Navigation achieved a revenue of 2.618 billion yuan, a year-on-year increase of 15.47%, and a net profit of 493 million yuan, up 26.41% year-on-year for the first three quarters [35] - Jingbeifang reported a revenue of 3.613 billion yuan, a year-on-year increase of 5.14%, and a net profit of 243 million yuan, up 7.94% year-on-year for the first three quarters [36] Group 13 - Weiergao achieved a revenue of 1.122 billion yuan, a year-on-year increase of 51.93%, and a net profit of 69.79 million yuan, up 48.11% year-on-year for the first three quarters [37] - Hanyi Co. reported a revenue of 139 million yuan, a year-on-year increase of 1.10%, and a net profit of 904,470 yuan, up 78.52% year-on-year for the first three quarters [38] - Boya Precision achieved a revenue of 387 million yuan, a year-on-year increase of 47.27%, and a net profit of 66.11 million yuan, up 82.87% year-on-year for the first three quarters [39] Group 14 - Qianfang Technology achieved a revenue of 5.256 billion yuan, a year-on-year decrease of 2.82%, and a net profit of 189 million yuan, up 1098.97% year-on-year for the first three quarters [40] - Binhua Co. submitted an application for H-share listing [41] - Chengde Lulu reported a revenue of 1.956 billion yuan, a year-on-year decrease of 9.42%, and a net profit of 384 million yuan, down 8.47% year-on-year for the first three quarters [42] Group 15 - Beifang Changlong reported a revenue of 122 million yuan, a year-on-year increase of 159.21%, but a net profit of 11.29 million yuan, turning from profit to loss for the first three quarters [43]

Core Viewpoint - Guangzheng Ophthalmology (002524.SZ) reported a year-on-year increase in operating revenue for Q3 2025, but net profit remains negative, indicating potential challenges in profitability despite revenue growth [1] Financial Performance - Operating revenue for Q3 2025 reached 227 million yuan, reflecting a year-on-year increase of 4.82% [1] - The net profit attributable to shareholders of the listed company was -1.2455 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -5.8955 million yuan [1]

Core Insights - The company reported a revenue of 663 million yuan for the first three quarters of 2025, representing a year-on-year decline of 5.05% [1] - The net profit attributable to shareholders of the listed company was 173,400 yuan, showing a significant year-on-year increase of 100.83% [1] - The net loss attributable to shareholders after deducting non-recurring gains and losses was 9.1753 million yuan [1]